M.D.C. Stock Forecast, Price & News

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last year. There are currently 4 hold ratings, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" M.D.C. stock.
View analyst ratings for M.D.C. or view top-rated stocks.

Wall Street analysts have given M.D.C. a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but M.D.C. wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

M.D.C. is scheduled to release its next quarterly earnings announcement on Tuesday, May 4th 2021.
View our earnings forecast for M.D.C..

M.D.C. Holdings, Inc. (NYSE:MDC) issued its quarterly earnings data on Tuesday, February, 2nd. The construction company reported $2.19 EPS for the quarter, topping the Zacks' consensus estimate of $1.73 by $0.46. The construction company earned $1.18 billion during the quarter, compared to analysts' expectations of $1.21 billion. M.D.C. had a trailing twelve-month return on equity of 16.78% and a net margin of 8.27%. The firm's revenue was up 9.9% on a year-over-year basis. During the same period last year, the firm posted $1.42 EPS.
View M.D.C.'s earnings history.

M.D.C.'s stock was trading at $33.96 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MDC shares have increased by 68.1% and is now trading at $57.08.
View which stocks have been most impacted by COVID-19.

M.D.C. announced a quarterly dividend on Thursday, January 28th. Shareholders of record on Wednesday, February 10th will be paid a dividend of $0.3429 per share on Wednesday, February 24th. This represents a $1.37 annualized dividend and a dividend yield of 2.40%. The ex-dividend date is Tuesday, February 9th.
View M.D.C.'s dividend history.

M.D.C. pays an annual dividend of $1.60 per share and currently has a dividend yield of 2.83%. M.D.C. does not yet have a strock track record of dividend growth. The dividend payout ratio of M.D.C. is 43.01%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, M.D.C. will have a dividend payout ratio of 24.62% next year. This indicates that M.D.C. will be able to sustain or increase its dividend.
View M.D.C.'s dividend history.

7 analysts have issued 1-year price targets for M.D.C.'s shares. Their forecasts range from $29.00 to $71.00. On average, they anticipate M.D.C.'s share price to reach $55.17 in the next year. This suggests that the stock has a possible downside of 3.4%.
View analysts' price targets for M.D.C. or view top-rated stocks among Wall Street analysts.

Some companies that are related to M.D.C. include D.R. Horton (DHI), Lennar (LEN), NVR (NVR), PulteGroup (PHM), Toll Brothers (TOL), KB Home (KBH), Meritage Homes (MTH), Tri Pointe Homes (TPH), Cavco Industries (CVCO), M/I Homes (MHO), Beazer Homes USA (BZH) and Hovnanian Enterprises (HOV).
View all of MDC's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Alibaba Group (BABA), Verizon Communications (VZ), The Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), The Home Depot (HD), Johnson & Johnson (JNJ), Pfizer (PFE) and QUALCOMM (QCOM).

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

M.D.C.'s stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.40%), CVentures Inc. (12.39%), Dimensional Fund Advisors LP (7.13%), Hamlin Capital Management LLC (2.41%), Northern Trust Corp (1.55%) and Bank of New York Mellon Corp (1.36%). Company insiders that own M.D.C. stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Leslie B Fox, Michael A Berman, Michael Touff, Paris G Reece III, Raymond T Baker, Robert Nathaniel Martin and Staci M Woolsey.
View institutional ownership trends for M.D.C..

MDC stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Clark Capital Management Group Inc., Bank of New York Mellon Corp, Walthausen & Co. LLC, Royce & Associates LP, Heartland Advisors Inc., Squarepoint Ops LLC, and JPMorgan Chase & Co.. Company insiders that have sold M.D.C. company stock in the last year include David D Mandarich, David Siegel, Larry A Mizel, Leslie B Fox, Paris G Reece III, Robert Nathaniel Martin, and Staci M Woolsey.
View insider buying and selling activity for M.D.C. or view top insider-selling stocks.

MDC stock was bought by a variety of institutional investors in the last quarter, including CVentures Inc., BlackRock Inc., Vision Capital Corp, Peregrine Capital Management LLC, Amundi Pioneer Asset Management Inc., South Street Advisors LLC, Riggs Asset Managment Co. Inc., and Healthcare of Ontario Pension Plan Trust Fund.
View insider buying and selling activity for M.D.C. or or view top insider-buying stocks.

Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MDC stock can currently be purchased for approximately $57.08.

M.D.C. has a market capitalization of $3.70 billion and generates $3.29 billion in revenue each year. The construction company earns $238.31 million in net income (profit) each year or $3.72 on an earnings per share basis.

M.D.C. employs 1,656 workers across the globe.

The official website for M.D.C. is www.mdcholdings.com.

M.D.C. is headquartered at 4350 S MONACO STREET SUITE 500, DENVER CO, 80237.

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The construction company can be reached via phone at 303-773-1100 or via email at [email protected]